Poly(l-lactide) (PLLA) was synthesized from l-lactide in
the presence of a zinc salen complex. Ofloxacin (OFLX)-loaded
PLLA nanofibrous mats were fabricated by electrospinning using dichloromethane/dimethyl
sulfoxide (4:1 v/v) solutions containing different amounts of OFLX
(1, 3, 5, and 10 w/w%). The morphology and diameter of nanofibrous
mats were studied by scanning electron microscopy (SEM). The internal
morphology of the nanofibers was examined by transmission electron
microscopy (TEM). Miscibility between OFLX and PLLA in nanofibrous
mats was confirmed by attenuated total reflection–Fourier transform
infrared (ATR–FTIR) spectroscopy. Differential scanning calorimetry
(DSC) confirmed the interaction of OFLX with PLLA nanofibrous mats.
The presence of OFLX in PLLA nanofibrous mats increased the tensile
strength significantly, which was confirmed by dynamic mechanical
analysis (DMA). The in vitro drug release profile
was studied at pH values 4.6, 5.8, and 7.4. OFLX-loaded PLLA nanofibrous
mats showed burst release till first 12 h, and sustained release followed
up to 168 h. The in vitro biocompatibility test of
nanofibrous mats was carried out using the 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl
tetrazolium bromide (MTT) assay against the NIH/3T3 fibroblast cell
line. The results of MTT assay demonstrated cell viability and cell
proliferation at a concentration as low as 10 w/w%, which proved their
nontoxicity and biocompatibility. OFLX-loaded PLLA nanofibrous mats
exhibited good antibacterial activity against Staphylococcus
aureus and Escherichia coli. The in vivo wound healing study on rats showed
44, 65, and 88% wound closure rates on 14th day with control, PLLA,
and OFLX-loaded PLLA nanofibrous mats, respectively. The results proved
that the PLLA nanofibrous mats loaded with an appropriate concentration
of OFLX are promising candidates for wound dressing applications.